Log in

Arvinas News Headlines (NASDAQ:ARVN)

$50.47
-0.23 (-0.45 %)
(As of 02/23/2020 06:48 AM ET)
Today's Range
$49.77
Now: $50.47
$50.87
50-Day Range
$41.60
MA: $49.27
$54.50
52-Week Range
$14.06
Now: $50.47
$54.95
Volume229,601 shs
Average Volume299,027 shs
Market Capitalization$1.70 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.69

Headlines

Arvinas (NASDAQ ARVN) News Headlines

Source:
DateHeadline
$4.77 Million in Sales Expected for Arvinas Inc (NASDAQ:ARVN) This Quarter$4.77 Million in Sales Expected for Arvinas Inc (NASDAQ:ARVN) This Quarter
www.americanbankingnews.com - February 23 at 3:08 AM
Zacks: Analysts Expect Arvinas Inc (NASDAQ:ARVN) Will Announce Earnings of -$0.56 Per ShareZacks: Analysts Expect Arvinas Inc (NASDAQ:ARVN) Will Announce Earnings of -$0.56 Per Share
www.americanbankingnews.com - February 21 at 5:34 AM
Arvinas, Inc. (ARVN) Upgraded to Buy: What Does It Mean for the Stock?Arvinas, Inc. (ARVN) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - February 17 at 2:59 PM
Arvinas Inc (NASDAQ:ARVN) Given Average Recommendation of "Buy" by AnalystsArvinas Inc (NASDAQ:ARVN) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - February 17 at 4:52 AM
Sean A. Cassidy Sells 10,000 Shares of Arvinas Inc (NASDAQ:ARVN) StockSean A. Cassidy Sells 10,000 Shares of Arvinas Inc (NASDAQ:ARVN) Stock
www.americanbankingnews.com - February 11 at 7:04 PM
What's in the Offing for Emerson (EMR) in Q1 Earnings?What's in the Offing for Emerson (EMR) in Q1 Earnings?
finance.yahoo.com - January 31 at 12:33 PM
Zacks: Analysts Anticipate Arvinas Inc (NASDAQ:ARVN) Will Post Quarterly Sales of $4.77 MillionZacks: Analysts Anticipate Arvinas Inc (NASDAQ:ARVN) Will Post Quarterly Sales of $4.77 Million
www.americanbankingnews.com - January 31 at 2:12 AM
Arvinas (NASDAQ:ARVN) PT Raised to $62.00Arvinas (NASDAQ:ARVN) PT Raised to $62.00
www.americanbankingnews.com - January 30 at 12:34 PM
 Analysts Expect Arvinas Inc (NASDAQ:ARVN) Will Post Earnings of -$0.56 Per Share Analysts Expect Arvinas Inc (NASDAQ:ARVN) Will Post Earnings of -$0.56 Per Share
www.americanbankingnews.com - January 29 at 5:31 PM
Shareholders Are Thrilled That The Arvinas (NASDAQ:ARVN) Share Price Increased 208%Shareholders Are Thrilled That The Arvinas (NASDAQ:ARVN) Share Price Increased 208%
finance.yahoo.com - January 17 at 8:45 AM
Did Hedge Funds Drop The Ball On Arvinas, Inc. (NASDAQ:ARVN) ?Did Hedge Funds Drop The Ball On Arvinas, Inc. (NASDAQ:ARVN) ?
finance.yahoo.com - December 19 at 7:01 PM
Arvinas to Present at the 31st Annual Piper Jaffray Healthcare ConferenceArvinas to Present at the 31st Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 27 at 7:45 AM
Arvinas TPD Therapies Have Great Potential, Guggenheim Says In Bullish InitiationArvinas TPD Therapies Have Great Potential, Guggenheim Says In Bullish Initiation
finance.yahoo.com - November 25 at 4:00 PM
Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of DirectorsArvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors
finance.yahoo.com - November 21 at 8:52 AM
Notable Insider Buys In The Past Week: Arvinas, Dropbox, TrinityNotable Insider Buys In The Past Week: Arvinas, Dropbox, Trinity
www.benzinga.com - November 17 at 1:49 PM
Healthcare Stocks That Hit New Highs (CBPO, CNMD, BHC...)Healthcare Stocks That Hit New Highs (CBPO, CNMD, BHC...)
www.finanznachrichten.de - November 15 at 8:58 AM
Arvinas, Inc. Announces Pricing of Public Offering of Common StockArvinas, Inc. Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - November 7 at 12:58 AM
Arvinas, Inc. Announces Proposed Offering of Common StockArvinas, Inc. Announces Proposed Offering of Common Stock
finance.yahoo.com - November 6 at 7:57 PM
Arvinas, Inc. (ARVN) Upgraded to Strong Buy: Here's WhyArvinas, Inc. (ARVN) Upgraded to Strong Buy: Here's Why
finance.yahoo.com - November 6 at 12:05 AM
Arvinas EPS misses by $0.07, beats on revenueArvinas EPS misses by $0.07, beats on revenue
seekingalpha.com - November 4 at 5:55 PM
Arvinas Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateArvinas Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - November 4 at 5:55 PM
Hedge Funds Are Selling Arvinas, Inc. (ARVN)Hedge Funds Are Selling Arvinas, Inc. (ARVN)
finance.yahoo.com - October 30 at 2:26 PM
Arvinas: Initial Clinical Data Provides Validation For PROTAC PlatformArvinas: Initial Clinical Data Provides Validation For PROTAC Platform
seekingalpha.com - October 29 at 12:24 PM
2 Biotech Stocks That Soared Last Week2 Biotech Stocks That Soared Last Week
www.fool.com - October 28 at 9:15 AM
ARVN Arvinas, Inc. Common StockARVN Arvinas, Inc. Common Stock
www.nasdaq.com - October 24 at 4:27 AM
Arvinas up 13% on encouraging cancer candidate dataArvinas up 13% on encouraging cancer candidate data
seekingalpha.com - October 23 at 2:41 PM
Have Insiders Been Buying Arvinas, Inc. (NASDAQ:ARVN) Shares This Year?Have Insiders Been Buying Arvinas, Inc. (NASDAQ:ARVN) Shares This Year?
finance.yahoo.com - October 19 at 2:14 PM
Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation SummitArvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd Targeted Protein Degradation Summit
finance.yahoo.com - October 17 at 7:18 AM
Arvinas Strengthens Scientific Advisory Board with Leaders in Oncology and Neurological DisordersArvinas Strengthens Scientific Advisory Board with Leaders in Oncology and Neurological Disorders
finance.yahoo.com - October 2 at 12:37 PM
Bayer funnels $55M into new startup with Triangle touchpointBayer funnels $55M into new startup with Triangle touchpoint
finance.yahoo.com - October 1 at 3:18 PM
Bayer and Arvinas launch new company togetherBayer and Arvinas launch new company together
seekingalpha.com - October 1 at 6:39 AM
Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth BioBayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
finance.yahoo.com - October 1 at 6:39 AM
Wedbush Starts Arvinas At Outperform, Says Lead Assets Could Have Successful TrialsWedbush Starts Arvinas At Outperform, Says Lead Assets Could Have Successful Trials
finance.yahoo.com - September 25 at 10:03 PM
Evercore likes Strongbridge Biopharma in premarket analyst actionEvercore likes Strongbridge Biopharma in premarket analyst action
seekingalpha.com - September 25 at 7:25 AM
Arvinas Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of ARV-471, anArvinas Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of ARV-471, an
www.nasdaq.com - August 27 at 12:22 PM
Arvinas launches clinical development of ARV-471Arvinas launches clinical development of ARV-471
seekingalpha.com - August 27 at 12:22 PM
Arvinas Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of ARV-471, an Estrogen Receptor-Targeting PROTAC® Protein DegraderArvinas Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of ARV-471, an Estrogen Receptor-Targeting PROTAC® Protein Degrader
finance.yahoo.com - August 27 at 12:22 PM
David Swensen Sells DocuSign in 2nd QuarterDavid Swensen Sells DocuSign in 2nd Quarter
finance.yahoo.com - August 16 at 3:59 PM
Arvinas To Present at the Wedbush PacGrow Healthcare ConferenceArvinas To Present at the Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 7 at 1:30 PM
JPMorgan upgrades Insulet after strong Q2JPMorgan upgrades Insulet after strong Q2
seekingalpha.com - August 6 at 11:10 AM
Arvinas Appoints Ronald Peck, M.D. as Chief Medical OfficerArvinas Appoints Ronald Peck, M.D. as Chief Medical Officer
finance.yahoo.com - July 29 at 10:32 AM
Arvinas Strengthens Board of Directors with Addition of Leslie NorwalkArvinas Strengthens Board of Directors with Addition of Leslie Norwalk
finance.yahoo.com - July 25 at 2:12 PM
Arvinas to Present Preclinical Tau-Directed PROTAC® Protein Degrader Data at Alzheimers Association International ConferenceArvinas to Present Preclinical Tau-Directed PROTAC® Protein Degrader Data at Alzheimer's Association International Conference
finance.yahoo.com - July 18 at 12:19 PM
Is Arvinas, Inc. (ARVN) A Good Stock To Buy?Is Arvinas, Inc. (ARVN) A Good Stock To Buy?
finance.yahoo.com - June 27 at 11:35 AM
Will Arvinas Continue to Surge Higher?Will Arvinas Continue to Surge Higher?
finance.yahoo.com - June 27 at 11:35 AM
Arvinas on go with early-stage study of ARV-471 in breast cancerArvinas on go with early-stage study of ARV-471 in breast cancer
seekingalpha.com - June 25 at 8:51 AM
Arvinas Receives Authorization to Proceed for ARV-471, a PROTAC® Protein Degrader to Treat Patients with Locally Advanced or Metastatic ER+ / HER2- Breast CancerArvinas Receives Authorization to Proceed for ARV-471, a PROTAC® Protein Degrader to Treat Patients with Locally Advanced or Metastatic ER+ / HER2- Breast Cancer
finance.yahoo.com - June 25 at 8:51 AM
Arvinas to Present at the BMO Prescriptions for Success Healthcare ConferenceArvinas to Present at the BMO Prescriptions for Success Healthcare Conference
finance.yahoo.com - June 20 at 9:02 AM
Bayer teams up with biotech firm Arvinas in deal worth up to $750 mlnBayer teams up with biotech firm Arvinas in deal worth up to $750 mln
www.nasdaq.com - June 4 at 12:09 PM
Bayer teams up with Arvinas in crop protectionBayer teams up with Arvinas in crop protection
seekingalpha.com - June 4 at 12:09 PM
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel